General Information
Pfizer Low Back Pain A4091059
A Phase 3, Randomized, Double Blind, Placebo and Active-Controlled, Multicenter, Parallel-Group Study of the Analgesic efficacy and Safety of Tanezumab in Adult Subjects with Chronic Low Back Pain.
| Protocol | A4091059 |
|---|---|
| Identifier | Site Number: 1131 Project Code #14PFZ032 |
| UID | 663ffbd1-58c7-44a6-b545-8bafd9a85bc3 |
| Status | Done - Archived |
| Phase | 3 |
| Category | Low Back Pain / Adult |
| Launch Year | 2015 |
| NCT Number | - |
| Created | 2015-05-15 09:36 |
| Last Updated | 2015-05-15 09:36 |
Description
No description provided.
Comment
CRI
Target Dates
| Name | Date | Required |
|---|---|---|
| Enrollment Closed | 2017-05-22 | No |
| Enrollment Open | 2015-10-13 | No |
| First Patient First Visit | No | |
| Site Initiation Mtg. | 2015-09-21 | No |
| PI Meeting Start | No | |
| PI Meeting End | No | |
| PI Meeting Arrival | No | |
| PI Meeting Departure | No | |
| Closeout Date | 2019-03-12 | No |
| Final PatientVisit | No | |
| PreStudy Selection Visit | No | |
| Target Date 12 | No | |
| Target Date 13 | No | |
| Target Date 14 | No |
Leadership
| Role | Staff | Login | Required |
|---|---|---|---|
| Principal | Martinez, Gilbert | GJMartinez | No |
| Recruiter | - | No | |
| Coordinator | Sandoval, Larry | LSandoval | No |
| Regulatory | Perez, Myrna | MPerez | No |
Custom Fields
No custom fields.
Sponsor & Organization
| Sponsor | Pfizer |
|---|---|
| Division | Pfizer |
| Team | Pfizer |
| Managing Site | Catalina Research Institute, LLC |
| Organization |
Contacts
| IRB Ref | |
|---|---|
| CRO | Inventiv Health Clinical, LLC |
| CRO Ref | |
| Correspondence | 0 |
Opportunity
| Probability | 0 |
|---|---|
| Comment | |
| Status Color | Gainsboro |
| Currency | - |
